Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma.

Autor: Wang JZ; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada.; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Patil V; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Landry AP; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada.; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Gui C; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada.; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Ajisebutu A; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Liu J; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Saarela O; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada., Pugh SL; NRG Oncology Statistics and Data Management Center, Philadelphia, PA, USA., Won M; NRG Oncology Statistics and Data Management Center, Philadelphia, PA, USA., Patel Z; Temerty School of Medicine, University of Toronto, Toronto, Ontario, Canada., Yakubov R; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Kaloti R; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Wilson C; Neurosurgery Specialists of Tulsa, Tulsa, OK, USA., Cohen-Gadol A; Department of Neurological Surgery, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA., Zaazoue MA; Department of Neurological Surgery, Indiana University School of Medicine, Indianapolis, IN, USA.; Department of Orthopedic Surgery, Washington University School of Medicine in St. Louis, St. Louis, MO, USA., Tabatabai G; German Cancer Consortium (DKTK), DKFZ Partner Site Tübingen, Tübingen, Germany.; Cluster of Excellence (EXC 2180) 'Image Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University Tübingen, Tübingen, Germany.; Department of Neurology and Interdisciplinary Neuro-Oncology, Center for Neuro-Oncology, Comprehensive Cancer Center, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Tübingen, Germany., Tatagiba M; Department of Neurosurgery, Center for Neuro-Oncology, Comprehensive Cancer Center, Eberhard Karls University Tübingen, Tübingen, Germany., Behling F; Department of Neurosurgery, Center for Neuro-Oncology, Comprehensive Cancer Center, Eberhard Karls University Tübingen, Tübingen, Germany., Almiron Bonnin DA; Department of Pathology, University of San Francisco, San Francisco, CA, USA., Holland EC; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Kruser TJ; Department of Human Oncology, University of Wisconsin Hospitals and Clinics, Madison, WI, USA., Barnholtz-Sloan JS; Central Brain Tumor Registry of the United States, Hinsdale, IL, USA.; Trans Divisional Research Program (TDRP), Division of Cancer Epidemiology and Genetics (DCEG), National Cancer Institute, Bethesda, MD, USA.; Center for Biomedical Informatics & Information Technology (CBIIT), National Cancer Institute, Bethesda, MD, USA., Sloan AE; Piedmont Brain Tumor Center, Piedmonth Healthcare System, Atlanta, GA, USA., Horbinski C; Department of Pathology, Northwestern University, Evanston, IL, USA.; Lou & Jean Malnati Brain Tumor Institute at the Lurie Comprehensive Cancer Center, Northwestern University, Evanston, IL, USA., Chotai S; Department of Neurosurgery, Vanderbilt University Medical Center, Nashville, TN, USA., Chambless LB; Department of Neurosurgery, Vanderbilt University Medical Center, Nashville, TN, USA., Gao A; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada., Rebchuk AD; Division of Neurosurgery, University of British Columbia, Vancouver, British Columbia, Canada., Makarenko S; Division of Neurosurgery, University of British Columbia, Vancouver, British Columbia, Canada., Yip S; Department of Pathology & Laboratory Medicine, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Sahm F; Department of Neuropathology, Institute of Pathology, Ruprecht-Karls-University Heidelberg, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Maas SLN; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Tsang DS; Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Rogers CL; Radiation Oncology, Utah Cancer Specialists, Salt Lake City, UT, USA., Aldape K; Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Nassiri F; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada. farshad.nassiri@uhn.ca.; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada. farshad.nassiri@uhn.ca.; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. farshad.nassiri@uhn.ca., Zadeh G; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada. gelareh.zadeh@uhn.ca.; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada. gelareh.zadeh@uhn.ca.; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. gelareh.zadeh@uhn.ca.; Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada. gelareh.zadeh@uhn.ca.

Publikováno v: Nature medicine [Nat Med] 2024 Aug 21. Date of Electronic Publication: 2024 Aug 21.

Comparative analysis of intraoperative and imaging features of invasive growth in pituitary adenomas.

Autor: Hladik M; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, 72076 Tübingen, Germany.; Department of Neurosurgery and Neurotechnology, University Hospital Tübingen, Eberhard-Karls-University Tübingen, 72076 Tübingen, Germany.; Department of Orthopedic, Trauma and Spine Surgery, Thun Hospital, 3600 Thun, Switzerland., Nasi-Kordhishti I; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, 72076 Tübingen, Germany.; Department of Neurosurgery and Neurotechnology, University Hospital Tübingen, Eberhard-Karls-University Tübingen, 72076 Tübingen, Germany., Dörner L; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, 72076 Tübingen, Germany.; Department of Neurosurgery and Neurotechnology, University Hospital Tübingen, Eberhard-Karls-University Tübingen, 72076 Tübingen, Germany., Kandilaris K; Faculty of Medicine, Medical Center, Institute for Surgical Pathology, Albert Ludwig University of Freiburg, 79098 Freiburg, Germany., Schittenhelm J; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, 72076 Tübingen, Germany.; Department of Neuropathology, University Hospital Tübingen, Eberhard-Karls-University Tübingen, 72076 Tübingen, Germany., Bender B; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, 72076 Tübingen, Germany.; Department of Diagnostic and Interventional Neuroradiology, University Hospital Tübingen, Eberhard-Karls-University Tübingen, 72076 Tübingen, Germany., Honegger J; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, 72076 Tübingen, Germany.; Department of Neurosurgery and Neurotechnology, University Hospital Tübingen, Eberhard-Karls-University Tübingen, 72076 Tübingen, Germany., Behling F; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, 72076 Tübingen, Germany.; Department of Neurosurgery and Neurotechnology, University Hospital Tübingen, Eberhard-Karls-University Tübingen, 72076 Tübingen, Germany.; Hertie Institute for Clinical Brain Research, 72076 Tübingen, Germany.

Publikováno v: European journal of endocrinology [Eur J Endocrinol] 2024 Jun 05; Vol. 190 (6), pp. 489-500.

Potential of pre-operative MRI features in glioblastoma to predict for molecular stem cell subtype and patient overall survival.

Autor: Eckert F; Department of Radiation Oncology, University of Tübingen, Germany; Medical University Vienna, Department of Radiation Oncology, Comprehensive Cancer Center Vienna, Vienna, Austria. Electronic address: franziska.eckert@meduniwien.ac.at., Ganser K; Department of Radiation Oncology, University of Tübingen, Germany., Bender B; Department of Diagnostic and Interventional Neuroradiology, University of Tübingen, Tübingen, Germany., Schittenhelm J; Department of Pathology and Neuropathology, University of Tübingen, Germany., Skardelly M; Department of Neurosurgery, University of Tübingen, Germany; Centre for Neurooncology, University of Tübingen, Germany., Behling F; Centre for Neurooncology, University of Tübingen, Germany., Tabatabai G; Centre for Neurooncology, University of Tübingen, Germany., Hoffmann E; Department of Radiation Oncology, University of Tübingen, Germany., Zips D; Department of Radiation Oncology, University of Tübingen, Germany; Department of Radiation Oncology, Charité Universitaetsmedizin Berlin, Germany., Huber SM; Department of Radiation Oncology, University of Tübingen, Germany., Paulsen F; Department of Radiation Oncology, University of Tübingen, Germany.

Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2023 Nov; Vol. 188, pp. 109865. Date of Electronic Publication: 2023 Aug 22.

Distribution of the immunohistochemical expression of BAP1 in meningiomas

Autor: Behling, F, Fodi, C, Skardelly, M, Schittenhelm, J, Honegger, JB, Tabatabai, G, Tatagiba, M, Beschorner, R

Publikováno v: 73. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Joint Meeting mit der Griechischen Gesellschaft für Neurochirurgie; 20220529-20220601; Köln; DOCP120 /20220525/

Objective: Meningiomas are mostly benign tumors arising from the arachnoid cap cells. However, prognostic assessment is important to identify cases with a tendency for a more aggressive behavior. The loss of the breast cancer (BRCA)1-associated prote

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fee53a74a1d4292903feb91afc837dac

The clinical and prognostic role of S100B expression in meningiomas

Autor: Behling, F., Fodi, C., Honegger, J., Tabatabai, G., Tatagiba, M., Schittenhelm, J.

Publikováno v: In Brain and Spine 2022 2 Supplement 2